These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36761410)

  • 1. Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer's disease.
    Frederiksen KS; Jensen CS; Høgh P; Gergelyffy R; Waldemar G; Andersen BB; Gottrup H; Vestergaard K; Wermuth L; Søndergaard HB; Sellebjerg F; Hasselbalch SG; Simonsen AH
    Front Neurosci; 2023; 17():1108191. PubMed ID: 36761410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer's Disease.
    Frederiksen KS; Larsen CT; Hasselbalch SG; Christensen AN; Høgh P; Wermuth L; Andersen BB; Siebner HR; Garde E
    Front Aging Neurosci; 2018; 10():293. PubMed ID: 30319397
    [No Abstract]   [Full Text] [Related]  

  • 3. Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design.
    Hoffmann K; Frederiksen KS; Sobol NA; Beyer N; Vogel A; Simonsen AH; Johannsen P; Lolk A; Terkelsen O; Cotman CW; Hasselbalch SG; Waldemar G
    Neuroepidemiology; 2013; 41(3-4):198-207. PubMed ID: 24135720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease.
    Jensen CS; Portelius E; Høgh P; Wermuth L; Blennow K; Zetterberg H; Hasselbalch SG; Simonsen AH
    Alzheimers Dement (N Y); 2017 Jun; 3(2):284-290. PubMed ID: 29067334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.
    Sobol NA; Dall CH; Høgh P; Hoffmann K; Frederiksen KS; Vogel A; Siersma V; Waldemar G; Hasselbalch SG; Beyer N
    J Alzheimers Dis; 2018; 65(1):137-145. PubMed ID: 30040719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a randomised trial of physical activity in Alzheimer's disease: a secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark.
    Sopina E; Sørensen J; Beyer N; Hasselbalch SG; Waldemar G
    BMJ Open; 2017 Jun; 7(6):e015217. PubMed ID: 28615271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of physical and cognitive function in performance of activities of daily living in patients with mild-to-moderate Alzheimer's disease - a cross-sectional study.
    Clemmensen FK; Hoffmann K; Siersma V; Sobol N; Beyer N; Andersen BB; Vogel A; Lolk A; Gottrup H; Høgh P; Waldemar G; Hasselbalch SG; Frederiksen KS
    BMC Geriatr; 2020 Nov; 20(1):513. PubMed ID: 33246408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
    Andersson E; Janelidze S; Lampinen B; Nilsson M; Leuzy A; Stomrud E; Blennow K; Zetterberg H; Hansson O
    Neurobiol Aging; 2020 Nov; 95():143-153. PubMed ID: 32810755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
    Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
    JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aerobic exercise on Neurofilament light chain and glial Fibrillary acidic protein level in patients with relapsing remitting type multiple sclerosis.
    Ercan Z; Bilek F; Demir CF
    Mult Scler Relat Disord; 2021 Oct; 55():103219. PubMed ID: 34433118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
    J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease.
    Frederiksen KS; Madsen K; Andersen BB; Beyer N; Garde E; Høgh P; Waldemar G; Hasselbalch SG; Law I
    Alzheimers Dement (N Y); 2019; 5():208-215. PubMed ID: 31198839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis.
    Forgrave LM; Ma M; Best JR; DeMarco ML
    Alzheimers Dement (Amst); 2019 Dec; 11():730-743. PubMed ID: 31909174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain level as a predictor of cognitive stage transition.
    Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J
    Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.